Skip to main content
SpringerLink
Log in

Lithium: Grundlagen und Therapie

  • Chapter
Psychopharmaka

Zusammenfassung

Die wichtigste Indikation für eine Therapie mit Lithiumsalzen ist die Anwendung zur Rückfallverhütung bei affektiven Psychosen („sekundäre Prävention“). Die phasenverhütende Wirkung von Lithium kann für Menschen, die unbehandelt weitere Rezidive von Depressionen, Manien oder schizoaffektiven Psychosen erleiden würden, einen großen Gewinn bedeuten: Die Lithiumtherapie befreit sie von der Angst vor Rückfällen, ermöglicht ihnen eine stabile Lebensführung und gewährleistet ihre soziale Integration. Weiterhin sind Lithiumsalze bei der Therapie der Manie von großer Bedeutung und werden neuerdings auch bei der Thyreotoxikose und bei der Granulozytopenie erfolgreich eingesetzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahlfors, U. G., Baastrup, P. C., Dencker, S. J., Elgen, K., Lingjaerde, O., Pedersen, V., Schou, M., Aaskoven, O. (1981): Flupenthixol decanoate in recurrent manic-depressive illness: a comparison with lithium. Acta Psychiat. Scand. 64, 226–237.

    CAS  Google Scholar 

  2. Albrecht, J. (1980): Effekte von Lithium auf die Schilddrüse. Inn. Med. 7, 69–75.

    CAS  Google Scholar 

  3. Albrecht, J. Moller-Oerlinghausen, B. (1980): Kardiovaskuläre Nebenwirkungen von Lithium. Dtsch. Med. Wschr. 105, 651–655.

    Article  PubMed  CAS  Google Scholar 

  4. Aldenhoff, J. B., Lux, H. D. (1982): Die Wirkung von Lithium auf Kalzium-abhängige Nervenzellen. Nervenarzt 53, 467–470.

    PubMed  CAS  Google Scholar 

  5. Amdisen, A. (1977): Serum level monitoring and clinical pharmacokinetics of lithium. Clin. Pharmacokinet. 2, 73–92.

    Article  PubMed  CAS  Google Scholar 

  6. Angrist, B., Gershon, S. (1979): Variable attenuation of amphetamine effects by lithium. Am. J. Psychiat. 136, 806–810.

    PubMed  CAS  Google Scholar 

  7. Angst, J., Dittrich, A., Grof, P. (1969): Course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int. Pharmacopsychiat. 2, 1–11

    Article  Google Scholar 

  8. Angst, J. (1981): Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver und schizoaffektiver Erkrankungen. In: Current perspectives in lithium prophylaxis (Berner, P., et al., Hrsg.) ( Bibliotheca psychiat., Vol. 161 ), S. 32–44. Basel: Karger.

    Google Scholar 

  9. Ayd, F. J. jr. (1978): Lithium intoxication in a spectinomycin-treated patient. Int. Drug. Ther. Newsl. 13, 15.

    Google Scholar 

  10. Baastrup, P. C. (1964): The use of lithium in manic-depressive psychosis. Compre-hens. Psychiat. 5, 396–408.

    Article  Google Scholar 

  11. Baastrup, P. C., Schou, M. (1967): Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch. Gen. Psychiat. 16, 162–172.

    Article  PubMed  CAS  Google Scholar 

  12. Bakris, G. L., Smith, D. W., Tiwari, S. (1981): Dermatological manifestations of lithium. A review. Int. J. Psychiat. Med. 10, 327.

    Article  CAS  Google Scholar 

  13. Baylis, P. H., Heath, D. A. (1978): Water disturbances in patients treated with oral lithium carbonate. Ann. Intern. Med. 88, 607–609.

    PubMed  CAS  Google Scholar 

  14. Bech, P., Thomsen, J., Rafaelsen, O. J. (1976): Long-term lithium treatment: effect on simulated driving and other psychological tests. Europ. J. Clin. Pharmacol. 10, 331–335.

    Article  CAS  Google Scholar 

  15. Belmaker, R. H. (1981): Receptors, adenylate cyclase, depression and lithium. Biol. Psychiat. 16, 333–350.

    PubMed  CAS  Google Scholar 

  16. Berl, S., Clarke, D. D. (1975): Lithium and amino acid metabolism. In: Lithium research and therapy ( Johnson, F. N., Hrsg.), S. 425–441. London: Academic Press.

    Google Scholar 

  17. Berner, P., Lenz, G., Wolf, R. (1981): Current perspectives in lithium prophylaxis (Bibliotheca psychiat., Vol 161 ). Basel: Karger.

    Google Scholar 

  18. Birch, N. J. (1976): Possible mechanism for biological action of lithium. Nature 264, 681.

    Article  PubMed  CAS  Google Scholar 

  19. Birch, N. J. (1980): Bone side-effects of lithium. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 365–371. Lancaster: MTP Press.

    Google Scholar 

  20. Blijenberg, B. G., Leijnse, B. (1968): The determination of lithium in serum by atomic absorption spectroscopy and flame emission spectroscopy. Clin. Chim. Acta 19, 97–99.

    Article  CAS  Google Scholar 

  21. Blum, S. F. (1979): Lithium therapy of aplastic anemia. New Engl. J. Med. 300, 677.

    CAS  Google Scholar 

  22. Boehm, T. M., Burman, K. D., Barnes, S., Wartofsky, L. (1981): Lithium and iodine combination therapy for thyreotoxicosis. Acta endocrinol.(Copenh.) 94, 174–183.

    Google Scholar 

  23. Brenner, R., Cooper, T. B., Michael, E., Yablonski, M. D., Lieberman, J. A., Lesser, M., Siris, S. G., Rifkin, A. E. (1982): Measurement of lithium concentrations in human tears. Am. J. Psychiat. 139, 678–679.

    PubMed  CAS  Google Scholar 

  24. Bunney, W. E. jr., Murphy, D. L. (1976): The neurobiology of lithium (Neurosciences Res. Prog. Bull., Vol. 14 ), S. 111–206.

    Google Scholar 

  25. Bunney, W. E. jr., Post, R. M., Amdisen, A. E., Kopanda, R. T. (1977): A neuronal receptor sensitivity mechanism in affective illness (a review of evidence). Psychopharmacol. Commun. 1, 393–405.

    Google Scholar 

  26. Cade, J. F. J. (1949): Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 36, 349–352.

    Google Scholar 

  27. Cade, J. F. J. (1978): Lithium–past, present and future. In: Lithium in medical practice ( Johnson, F. N., Johnson, S., Hrsg.), S. 5–16. Lancaster: MTP Press.

    Google Scholar 

  28. Cameron, O. G., Smith, C. B. (1980): Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices. Psychopharmacol. 67, 81–85.

    Article  CAS  Google Scholar 

  29. Carroll, B. J. (1979): Prediction of treatment outcome with lithium. Arch. Gen. Psychiat. 36, 870–878.

    Article  PubMed  CAS  Google Scholar 

  30. Cooper, T. B., Gershon, S., Kline, N. S., Schou, M., Hrsg. (1979): Lithium: Controversies and unresolved issues. Amsterdam: Excerpta Medica.

    Google Scholar 

  31. Cooper, T. B. (1980): Monitoring lithium dose levels: estimation of lithium in blood. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 169–178. Lancaster: MTP Press.

    Google Scholar 

  32. Coppen, A., Montgomery, S. A., Gupta, R. K., Bailey, J. E. (1976): A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br. J. Psychiat. 128, 479–485.

    Article  CAS  Google Scholar 

  33. Coppen, A., Ghose, H., Rao, R., Bailey, J., Peet, M. (1978): Mianserin and lithium in the prophylaxis of depression. Br. J. Psychiat. 133, 206–210.

    Article  CAS  Google Scholar 

  34. Coppen, A., Metcalfe, M., Wood, K. (1982): Lithium. In: Handbook of affective disorders ( PAYKEL, E. S., Hrsg.), S. 276–285. Edinburgh: Churchill Livingstone.

    Google Scholar 

  35. Corcoran, A. C., Taylor, R. D., Page, I. H. (1949): Lithium poisoning from the use of salt substitute. J. Am. med. Ass. 139, 685–688.

    Article  CAS  Google Scholar 

  36. Corrodi, H., Fuxe, K., Schou, M. (1969): The effect of prolonged lithium administration on cerebral monoamine neurons in the rat. Life Sci. 8, 643–651.

    Article  PubMed  CAS  Google Scholar 

  37. Cox, M., Singer, I. (1979): Lithium-induced natriuresis. In: Lithium: Controversies and unresolved issues ( Cooper, T. B. et al., Hrsg.), S. 646–654. Amsterdam: Excerpta Medica.

    Google Scholar 

  38. Creese, I., Sibley, D. R. (1981): Receptor adaptations to centrally acting drugs. Ann. Rev. Pharmacol. Toxicol. 21, 357–391.

    Article  CAS  Google Scholar 

  39. Davis, K. L., Berger, P. A., Hollister, L. E., Barchas, J. D. (1978): Cholinergic involvement in Mental Disorders. Life Sci. 22, 1865–1872.

    Article  PubMed  CAS  Google Scholar 

  40. Davis, J. M. (1976): Overview: Maintenance therapy in psychiatry. II. Affective disorders. Am. J. Psychiat. 133, 1–13.

    PubMed  CAS  Google Scholar 

  41. Delva, N. J., Letemendia, F. J. J. (1982): Lithium treatment in schizophrenia and schizo-affective disorders. Br. J. Psychiat. 141, 387–400.

    Article  CAS  Google Scholar 

  42. Dempsey, G. M., Dunner, D. L., Fieve, R. R., Farkas, T., Wong, J. (1976): Treatment of excessive weight gain in patients taking lithium. Am. J. Psychiat. 133, 1082–1084.

    PubMed  CAS  Google Scholar 

  43. Dorus, E., Pandey, G. N., Shaughnessy, R., Gaviria, M., Val, E., Ericksen, S. Davis, J. M. (1979): Lithium transport across red cell membrane: a cell membrane abnormality in manic-depressive illness. Science 205, 932–934.

    Article  PubMed  CAS  Google Scholar 

  44. Duhm, J., Eisenried, F., Becker, B. F., Greil, W. (1976): Studies on the lithium transport across the red cell membrane. I. Li+ uphill transport by the Na+ dependent Li+ counter-transport system of human erythrocytes. Pflügers Arch. 364, 147–155.

    Article  PubMed  CAS  Google Scholar 

  45. Duhm, J., Becker, B. F. (1977): Studies on the lithium transport across the red cell membrane. II. Characterization of ouabain-sensitive and ouabain-insensitive Li+ transport. Effects of bicarbonate and dipyridamole. Pflügers Arch. 367, 211–219.

    Article  PubMed  CAS  Google Scholar 

  46. Duhm, J., Becker, B. F., Greil, W. (1979): Na+ dependent Li+ countertransport and the lithium distribution across the human erythrocyte membrane: an introduction. In: Biological psychiatry today ( Obiols, J., et al., Hrsg.), S. 1137–1142. Amsterdam: North-Holland Biomedical Press Elsevier.

    Google Scholar 

  47. Ebstein, R., Belmaker, R., Grunhaus, L., Rimon, R. (1976): Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature 259, 411–413.

    Article  PubMed  CAS  Google Scholar 

  48. Editorial (1979): Lithium and the kidney: grounds for cautions optimisms. Lancet 2, 1056–1057.

    Google Scholar 

  49. Edström, A., Persson, G. (1977): Comparison of side effects with coated lithium carbonate tablets and lithium sulphate preparations giving medium–slow and slow release. A double-blind cross-over study. Acta Psychiat. Scand. 55, 153–158.

    Google Scholar 

  50. Ehrlich, B. E., Diamond, J. M. (1980): Lithium, membranes, and manic-depressive illness. J. Membrane Biol. 52, 187–200.

    Article  CAS  Google Scholar 

  51. Eichner, D., Opitz, K. (1974): Über den natürlichen Lithiumgehalt tierischer Gewebe. Histochemistry 42, 295–300.

    Article  PubMed  CAS  Google Scholar 

  52. Eisenried, F., Greil, W., Scheit, A. J. (1982): Natrium-Lithium-Gegentransport in Erythrozyten bei affektiven Psychosen. In: Biologische Psychiatrie ( Beckmann, H., Hrsg.), S. 253–258. Stuttgart-NewYork: G. Thieme.

    Google Scholar 

  53. Emrich, H. M., Aldenhoff, J. B., Lux, H. D. (Hrsg.) (1982): Basic mechanisms in the action of lithium. Amsterdam: Excerpta Medica.

    Google Scholar 

  54. Emrich, H. M., (1982): Prophylactic therapies in affective disorders: mode of action from a clinical point of view. In: Basic mechanisms in the action of lithium (Enrich, H. M. et al., Hrsg.), S. 202–214. Amsterdam: Excerpta Medica.

    Google Scholar 

  55. Felber, W., König, L., Lange, E. (1981): Rehabilitative Ziele in der Psychiatrie–die Lithiumbehandlung affektiver Psychosen. Dt. Gesundh.-Wesen 36, 289–293.

    Google Scholar 

  56. Forrest, J. N. (1979): Lithium-induced polyuria: cellular mechanisms and response to diuretics. In: Lithium: Controversies and unresolved issues (Cooper, T. B. et al., Hrsg.), S. 632–640. Amsterdam: Excerpta Medica.

    Google Scholar 

  57. Franks, R., Dubovsky, L. S., Lifshits, M., Coen, P., Subryan, V., Walker, S. H. (1982): Long-term lithium carbonate therapy causes hyperparathyreoidism. Arch. Gen. Psychiat. 39, 1074–1077.

    Article  PubMed  CAS  Google Scholar 

  58. Friedenberg, W. R., May, J. J. (1980): The effect of lithium carbonate on lymphocyte, granulocyte and platelet function. Cancer 45, 91–97.

    Article  PubMed  CAS  Google Scholar 

  59. Frölich, J. C., Leftwich, R., Ragbeh, M., Oates, J. A., Reimann, I., Buchanan, D. (1979): Indomethacin increases plasma lithium. Br. Med. J. 1, 1115–1116.

    Article  PubMed  Google Scholar 

  60. Gelfand, E. W., Dosche, H. M., Hastings, D. (1979): Lithium: a modulator of cyclic AMP-dependent events in lymphocytes. Science 203, 365–367.

    Article  PubMed  CAS  Google Scholar 

  61. Gerbino, L., Oleshansky, M., Gershon, S. (1978): Clinical uses and mode of action of lithium. In: Psychopharmacology: A generation of progress ( Lipton, M. A. et al., Hrsg.), S. 1261–1275. New York: Raven Press.

    Google Scholar 

  62. Gerdes, H. (1978): Symptomatologie und Therapie der Lithium-Intoxikation. Internist 19, 252–254.

    PubMed  CAS  Google Scholar 

  63. Gershengorn, M. C., Izumi, M., Robbins, J. (1976): Use of lithium as an adjunct to radioiodine therapy of thyroid carcinomas. J. clin. Endocr. Metab. 42, 105–111.

    Article  PubMed  CAS  Google Scholar 

  64. Gershon, S., Shopsin, B., Hrsg. (1973): Lithium: Its role an psychiatric research and treatment. New York: Plenum Press.

    Google Scholar 

  65. Gillin, J. C., Hong, J. S., Yang, H.-Y., Costa, E. (1979): Does lithium act by selectively affecting a brain enkephalin system? In: Lithium: Controversies and unresolved issues (Cooper, T. B. et al., Hrsg.), S. 781788. Amsterdam: Excerpta Medica.

    Google Scholar 

  66. Girke, W., Krebs, F. A., Müller-Oerlinghausen, B. (1975): Effects of lithium on electromyographic recordings in man. Studies in manic-depressive patients and normal volunteers. Pharmacopsychiat. 10, 24–36.

    CAS  Google Scholar 

  67. Goodnick, P. J., Fieve, R. R., Meltzer, H. L., Dunner, D. L. (1981): Lithium elimination half-life and duration of therapy. Clin. Pharmacol. Ther. 29, 47–50.

    Article  PubMed  CAS  Google Scholar 

  68. Goodwin, F. K. (ed.) (1979): Introduction (und folgende Arbeiten). Arch. Gen. Psychiat. 36, 833–916.

    Google Scholar 

  69. Goodwin, F. K., Zis, A. P. (1979): Lithium in the treatment of mania. Arch. Gen. Psychiat. 36, 840–844.

    Article  PubMed  CAS  Google Scholar 

  70. Greco, F. A., Brereton, H. D. (1977): Effect of lithium carbonate on neutropenia caused by chemotherapy: a preliminary trial. Oncology 34, 153–155.

    Article  PubMed  CAS  Google Scholar 

  71. Greil, W., Sold, M., Patscheke, H., Brossmer, R. (1973): Effect of Li+, Na+ and K+ on Ca++ dependent human platelet aggregation: stimulation by K+, inhibition by Li+. In: Erythrocytes, thrombocytes, leukocytes ( Gerlach, E. et al., Hrsg.), S. 284–287. Stuttgart: G. Thieme.

    Google Scholar 

  72. Greil, W., Schnelle, K., Seibold, S. (1974): Intra/extrazelluläres Lithiumverhältnis. Klinische und experimentelle Untersuchung an Thrombozyten und Erythrozyten. Arzneim.-Forsch. 24, 1079–1084.

    CAS  Google Scholar 

  73. Greil, W. (1977): Therapie mit Lithiumsalzen und Rezidivverhütung bei phasischen Psychosen. Therapiewoche 27, 1286–1300.

    CAS  Google Scholar 

  74. Greil, W., Eisenried, F., Becker, B. F., Duhm, J. (1977): Interindividual differences in the Na+-dependent Li+ -counter-transport system and in the Li+-distribution ratio across the red cell membrane amongst Li+-treated patients. Psychopharmacol. 53, 19–26.

    Article  CAS  Google Scholar 

  75. Greil, W., Eisenried, F. (1978): Lithium uptake by erythrocytes of lithium treated patients: interindividual differences. In: Lithium in medical practice ( Johnson, F. N., Johnson, S., Hrsg.), S. 415–420. Lancaster: MTP Press.

    Google Scholar 

  76. Greil, W. (1981): Pharmakokinetik und Toxikologie des Lithiums. Bibliotheca psychiat. 161, 69–103.

    Google Scholar 

  77. Greil, W. (1982): Zu den Mechanismen der Verteilung von Lithium zwischen Erythrozyten und Plasma. Nervenarzt 53, 461–466.

    PubMed  CAS  Google Scholar 

  78. Greil, W., Broucek, B., Klein, H. E., Engel-Sittenfeld, P. (1982): Discontinuation of lithium maintenance therapy: reversibility of clinical, psychological and neuroendocrinological changes. In: Basic mechanisms in the action of lithium (Em-Rich, H. M., et al., Hrsg.), S. 235–248. Amsterdam: Excerpta Medica.

    Google Scholar 

  79. Greil, W., Haag, H., Schertel, M. (1983): Affective disorders. In: Psychopharmacology I, Part 2: Clinical Psychopharmacology ( Hippius, H., Winokur, G., Hrsg.), S. 231–249. Amsterdam: Excerpta Medica.

    Google Scholar 

  80. Grof, P., Angst, J., Karasek, M., Keitner, G. (1979): Patient selection for long-term lithium treatment in clinical practice. Arch. Gen. Psychiat. 36, 894–897.

    Article  PubMed  CAS  Google Scholar 

  81. Grof, P. (1979): Some practical aspects of lithium treatment. Arch. Gen. Psychiat. 36, 891–893.

    Article  PubMed  CAS  Google Scholar 

  82. Grof, P. (1982) (zit. nach AYD, F. J., Hrsg.): Int. Drug. Ther. Newsl. 17, 13–14.

    Google Scholar 

  83. Grona, R., Grell, W., Jungkunz, G., Engel-Sittenfeld, P. (1978): Verhaltenstherapie in der Gruppe als psychologische Zusatzbehandlung bei der Lithiumprophylaxe affektiver Psychosen. Arzneim.-Forsch./ Drug Res. 28, 1521–1522.

    CAS  Google Scholar 

  84. Gupta, R. K., Montgomery, S. (1975): Status of lithium patients as blood donors (letter to. ed.). Lancet 1, 860.

    Article  PubMed  CAS  Google Scholar 

  85. Gupta, R. C., Robinson, W. A., Kurnick, J. E. (1976): Felty’s syndrome–effect of lithium on granulopoiesis. Amer. J. Med. 61, 29–32.

    Article  PubMed  CAS  Google Scholar 

  86. Haas, M., Schooler, J., Tosteson, D. C. (1975): Coupling of lithium to sodium transport in human red cells. Nature 258, 425–426.

    Article  PubMed  CAS  Google Scholar 

  87. Hamprecht, B. (1977): Structural, electrophysiological, biochemical and pharmacological properties of neuroblastoma x glioma hybrid cells in cell culture. Int. Rev. Cytol. 49, 99–170.

    Article  PubMed  CAS  Google Scholar 

  88. Hanin, I., Mallinger, A. G., Kopp, V., Himmelhoch, J. M., Neil, J. F. (1980): Mechanisms of lithium-induced elevation in red blood cells choline content: an in vitro analysis. Commun. Psychopharmacol. 4, 345–355.

    PubMed  CAS  Google Scholar 

  89. Hansen, H. E., Amdisen, A. (1978): Lithium intoxication. Q. J. Med. 47, 123–144.

    PubMed  CAS  Google Scholar 

  90. Hartigan, G. P. (1963): The use of lithium salts in affective disorders. Br. J. Psychiat. 109, 810–814.

    Article  CAS  Google Scholar 

  91. Helmchen, H., Kanowski, S. (1971): EEG-Veränderungen unter Lithium-Therapie. Nervenarzt 42, 144–148.

    PubMed  CAS  Google Scholar 

  92. Hendler, N. H. (1978): Lithium pharmacology and physiology. In: Handbook of psychopharmacology; Affective disorders: Drug action in animals and man ( Iversen, L. L., et al., Hrsg.), Vol. 14, S. 233–273. New York–London: Plenum Press.

    Google Scholar 

  93. Hofmann, G. Grünberger, J., König, P., Presslich, O., Wolf, R. (1974): Die mehrjährige Lithiumtherapie affektiver Störungen. Langzeiteffekte und Begleiterscheinungen. Psychiat. clin. 7, 129–148.

    CAS  Google Scholar 

  94. Horrobin, D. F. (1979): Lithium as a regulator of prostaglandin synthesis. In: Lithium: Controversies and unresolved issues (Cooper, T. B., et al., Hrsg.), S. 854–880. Amsterdam: Excerpta Medica.

    Google Scholar 

  95. Hullin, R. P. (1975): The effects of Lithium on electrolyte balance and body fluids. In: Lithium research and therapy ( Johnson, F. N., Hrsg.), S. 359–379. London: Academic Press.

    Google Scholar 

  96. Hullin, R. P. (1980): Minimum serum lithium levels for effective prophylaxis. In: Handbook of lithium therapy (Johnson, F. N.), S. 243–247. Lancaster: MTP Press.

    Google Scholar 

  97. Jamison, K. R., Gerner, R. H., Goodwin, F. K. (1979): Patient and physician attitudes toward lithium. Arch. Gen. Psychiat. 36, 866–869.

    Article  PubMed  CAS  Google Scholar 

  98. Jefferson, J. W., Greist, J. H. (1977): Primer of lithium therapy, S. 201–207. Baltimore: Williams Wilkins.

    Google Scholar 

  99. Jefferson, J. W., Greist, J. H. Marcetich, J. R. (1979): The lithium information center. In: Lithium: Controversies and unresolved issues ( Cooper, T. B., et al., Hrsg.), S. 958–963. Amsterdam: Excerpta Medica.

    Google Scholar 

  100. Jefferson, J. W. (1980): Diuretics are dangerous with lithium. Br. Med. J. 281, 1217.

    Article  PubMed  CAS  Google Scholar 

  101. Johnson, F. N. (Hrsg.) (1975): Lithium research and therapy. London: Academic Press.

    Google Scholar 

  102. Johnson, F. N., Johnson, S. (Hrsg.) (1978): Lithium in medical practice. Lancaster: MTP Press.

    Google Scholar 

  103. Johnson, F. N. (1978): The variety of models proposed for the therapeutic actions of lithium. In: Lithium in medical practice ( Johnson, F. N., Johnson, S., Hrsg.). Lancaster: MTP Press.

    Google Scholar 

  104. Johnson, F. N. (Hrsg.) (1980): Handbook of lithium therapy. Lancaster: MTP Press.

    Google Scholar 

  105. Johnson, F. N. (1980): Social and psychological supportive measures during lithium therapy. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 248–254. Lancaster: MTP Press.

    Google Scholar 

  106. Johnson, F. N. (1980): The choice of an appropiate lithium preparation. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 225–236. Lancaster: MTP Press.

    Google Scholar 

  107. Johnsson, A., Pflug, B., Engelmann, W., Klemke, W. (1979): Effect of lithium carbonate on circadian periodicity in humans. Neuro-Psychopharmakol. 12, 423.

    CAS  Google Scholar 

  108. Johnson, A., Engelmann, W. (1980): In 1985. Lithium: Grundlagen und Therapie fluence of lithium ions on human circadian rhythms. Z. Naturforsch. 35c, 503–507.

    Google Scholar 

  109. Jope, R. S. (1979): Effects of lithium treatment in vitro and in vivo on acetylcholine metabolism in rat brain. J. Neurochem. 33, 487–495.

    Article  PubMed  CAS  Google Scholar 

  110. Jope, R. S., Jenden, D. J., Ehrlich, B. E., Diamond, J. M. (1978): Choline accumulates in erythrocytes during lithium therapy. N. Engl. J. Med. 299, 833–834.

    PubMed  CAS  Google Scholar 

  111. Judd, L. L. (1979): Effect of lithium onmmood, cognition, and personality function in normal subjects. Arch. Gen. Psychiat. 36, 860–865.

    Article  PubMed  CAS  Google Scholar 

  112. Kafka, M. S., Wirz-Justice, A., Naber, D., Marangos, P. J., O’donohue, T. L., Wehr, T. A. (1982): Effect of lithium on circadian neurotransmitter receptor thythms Neu_ropsychobiol. 8, 41–50.

    CAS  Google Scholar 

  113. Kampf, D., Müller-Oerlinghausen, B., Albrecht, J., Kessel, M. (1983): Lithium-Prophylaxe: Nephrotoxizität und therapeutische Konsequenzen. Internist 24, 110–116.

    PubMed  CAS  Google Scholar 

  114. Kane, J. M., Quitkin, F. M., Rifkin, A., Ramos-Lorenzi, J. R., Nayak, D. D., HoWard, A. (1982): Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. A prospective, placebo-controlled comparison. Arch. Gen. Psychiat. 39, 1065–1069.

    Article  PubMed  CAS  Google Scholar 

  115. Kincaid-Smith, P., Burrows, G. D., Da-Vies, B. M., Holwill, B., Walter, M., Walker, R. G. (1979): Renal-biopsy findings in lithium and prelithium patients. Lancet 11, 700–701.

    Article  Google Scholar 

  116. Kirchmair, H., Kirchmair, W. (1982): Kardiovaskuläre Nebenwirkungen unter Lithium-Therapie. Neuropsychiat. Clin. 1, 59–65.

    Google Scholar 

  117. Klein, H. E., Broucek, B., Greil, W. (1981): Lithium withdrawal triggers psychotic states. Br. J. Psychiat. 139, 255–256.

    Article  CAS  Google Scholar 

  118. Knapp, S. (1983): Lithium. In: Psychopharmacology, Part 1: Preclinical Psychopharmacology ( Grahame-Smith, D. G., Co-Wen, P. J., Hrsg.), S. 71–106. Amsterdam: Excerpta Medica.

    Google Scholar 

  119. Knapp, S., Mandell, A. J. (1973): Short-and long-term lithium administration: Effects of the brain’s serotonergic biosynthetic systems. Science 180, 645–647.

    Article  PubMed  CAS  Google Scholar 

  120. Kurek, M., Consbruch, U. (1982): Acht Jahre Lithiumkatamnese in einer nervenärztlichen Praxis. Pharmacopsychiat. 15, 65–69.

    Article  CAS  Google Scholar 

  121. Lanoir, J. (1978): Lithium and states of alertness. In: Advances in the biosciences (Pharmacology of the states of alertness) (Passomaut, P., Oswald, I., Hrsg.), Vol. 21, S. 157–167.

    Google Scholar 

  122. Leber, P. (1981): Lithium leukocytosis and leukemia: the probable influence of biological plausibility on clinical concern. Psychopharmacol. Bull. 17, 10–13.

    PubMed  CAS  Google Scholar 

  123. Lenz, G., Küfferle, B., Wolf, R. (1981): Lithiumprophylaxe schizoaffektiver Psychosen. In: Current perspectives in lithium prophylaxis (Berner, P., et al., Hrsg.(Bibliotheca psychiat. 161 ), S. 45–57. Basel: Karger.

    Google Scholar 

  124. Levitzki, A., Atlas, D. (1981): A possible molecular mechanism for 0-receptor desensitization: Experiments and hypotheses. Life Sci. 28, 661–672.

    Article  PubMed  CAS  Google Scholar 

  125. Lydiard, R. B., Gelenberg, A. J. (1982): Hazards and adverse effects of lithium. Ann. Rev. Med. 33, 327–344.

    Article  PubMed  CAS  Google Scholar 

  126. Matussek, N., Müller, S. (1974): Effect of chronic lithium treatment on behaviour and on norepinephrine metabolism in rat brain in a norepinephrine-deficient state. In: Neuropsychopharmacology, Proceedings of the IX Congress of the Collegium Internationale Neuropsychopharmacologicum, S. 612–616. Amsterdam: Excerpta Medica.

    Google Scholar 

  127. Maccullum, W. A. G. (1980): Interaction of lithium and phenytoin. Br. Med. J. 280, 610–611.

    Article  Google Scholar 

  128. Mann, J., Gershon, S. (1980): Absolute and relative contra-indications to lithium treatment. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 265–278. Lancaster: MTP Press.

    Google Scholar 

  129. Martin, B. A., Kramer, P. M. (1982): Clinical significance of the interaction between lithium and a neuromuscular blocker. Am. J. Psychiat. 139, 1326–1328.

    PubMed  CAS  Google Scholar 

  130. Mathew, N. T. (1977): Lithium therapy in cluster headache. Headache 17, 92–93.

    Google Scholar 

  131. Mcgennis, A. J. (1978): Lithium carbonate and tetracycline interaction. Br. Med. J. 1, 1183.

    Article  PubMed  CAS  Google Scholar 

  132. Mendels, J., Ramsey, T. A., Dyson, W. L., Frazer, A. (1979): Lithium as an antidepressant. Arch. Gen. Psychiatry 36, 845–846.

    Article  PubMed  CAS  Google Scholar 

  133. Merry, J., Reynolds, C. M., Bailey, J., Coppen, A. (1976): Prophylactic treatment of alcoholism by lithium carbonate. A controlled study. Lancet 2, 481–482.

    Article  Google Scholar 

  134. Millington, W. R., Mccall, A. L., Wurtman, R. J. (1979): Lithium and brain choline levels. N. Engl. J. Med. 300, 196–197.

    Article  PubMed  CAS  Google Scholar 

  135. De Montigny, C., Grunberg, F., Mayer, A., Deschenes, J.-P. (1981): Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. Br. J. Psychiat. 138, 252–256.

    Article  Google Scholar 

  136. Müller-Oerlinghausen, B., Passoth, P.-M., Poser, W., Pudel, V. (1979): Impaired glucose tolerance in long-term lithium-treated patients. Int. Pharmacopsychiat. 14, 350–362.

    Google Scholar 

  137. Müller-Oerlinghausen, B. (1977): 10 Jahre Lithiumkatamnese. Nervenarzt 48, 483–493.

    PubMed  Google Scholar 

  138. Müller-Oerlinghausen, B., Albrecht, J., Kampf, D. (1981): Lithium-Prophylaxe und Nierenfunktion–zusammenfassende Beurteilung und Richtlinien zur Therapieüberwachung. Nervenarzt 52, 113–115.

    PubMed  Google Scholar 

  139. Müller-Oerlinghausen, B. (1982): Psychological effects, compliance, and response to long-term lithium. Br. J. Psychiat. 141, 411–419.

    Article  Google Scholar 

  140. Nathanson, J. A. (1977): Cyclic nucleotides and nervous system function. Physiol. Rev. 57, 157–253.

    PubMed  CAS  Google Scholar 

  141. Noack, C. H., Trautner, E. M. (1951): The lithium treatment of maniacal psychosis. Med. J. Aust. 38, 219–222.

    Google Scholar 

  142. Nolen, W. A. (1981): Carbamazepine (Tegretol wellicht een alternatief voor lithium? Tijdschrift voor psychiatrie 23, 462–472.

    Google Scholar 

  143. Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A., Watanabe, S. (1981): A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacol. 73, 9596.

    Google Scholar 

  144. Orr, L. E., Mckernan, J. F. (1979): Lithium reinduction of acute myeloblastic leukaemia. Lancet 1, 449–450.

    Article  PubMed  CAS  Google Scholar 

  145. Pandey, G. N., Dorus, E., Davis, J. M., Tosteson, D. C. (1979): Lithium transport in human red blood cells. Genetic and clinical aspects. Arch. Gen. Psychiat. 36, 902–908.

    Article  PubMed  CAS  Google Scholar 

  146. Perez-Cruet, J., Waite, J., Mallya, A., Khajawall, A. M. (1979): Effects of lithium on thymus gland mediated functions in man and rodents. In: Lithium: Controversies and unresolved issues ( Cooper, T. B., et al., Hrsg.), S. 881–894. Amsterdam: Excerpta Medica.

    Google Scholar 

  147. Pert, A., Rosenblatt, E., Sivit, C., Pert, C. B., Bunney, W. E. jr. (1978): Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201, 171–173.

    Article  PubMed  CAS  Google Scholar 

  148. Pert, A. Bunney, W. E. jr. (1982): Chronic lithium modulates neurotransmitter receptor sensitivity. In: Basic mechanisms in the action of lithium ( Emrich, H. M., et al., Hrsg.), S. 121–132. Amsterdam: Excerpta Medica.

    Google Scholar 

  149. Plenge, P., Mellerup, E. T., Bolwig, T. G., Brun, C., Hetmar, O., Ladefoged, J., Larsen, S., Rafaelsen, O. J. (1982): Lithium treatment: Does the kidney prefer one daily dose instead of two? Acta Psychiat. Scand. 66, 121–128.

    CAS  Google Scholar 

  150. Plenge, P., Mellerup, E. T., Norgaard, T. (1981): Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment. Acta Psychiat. Scand. 63, 303–313.

    CAS  Google Scholar 

  151. Prien, R. F., Klett, C. J., Caffey, E. M. (1973): Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch. Gen. Psychiat. 29, 420–425.

    Article  PubMed  CAS  Google Scholar 

  152. Prien, R. F., Caffey, E. M. (1976): Relationship between dosage and response to lithium prophylaxis in recurrent depression. Am. J. Psychiat. 133, 567–570.

    PubMed  CAS  Google Scholar 

  153. Prien, R. J. (1979): Lithium in the treatment of schizophrenia and schizoaffective disorders. Arch. Gen. Psychiat. 36, 852–853.

    Article  PubMed  CAS  Google Scholar 

  154. Rafaelsen, O. J., Bolwing, T. G., Ladefoged, J., Brun, C. (1979): Kidney function and morphology in long term treatment with lithium. Arch. Gen. Psychiat. 36, 578–583.

    Google Scholar 

  155. Ragheb, M., Ban, T. A., Buchanan, D., Frolich, J. C. (1980): Interaction of indomethacin and ibuprofen with lithium in manic patients under a steadystate lithium level. J. Clin. Psychiat. 41, 397–398.

    CAS  Google Scholar 

  156. Ramsey, T. A., Cox, M. (1982): Lithium and the kidney: A review. Am. J. Psychiat. 139, 443–449.

    PubMed  CAS  Google Scholar 

  157. Reginaldi, D., Tondo, L., Floris, G., Pignatelli, A., Kukopulos, A. (1981): Poor prophylactic lithium response due to antidepressants. Int. Pharmacopsychiat. 16, 124–128.

    CAS  Google Scholar 

  158. Reisberg, B., Gershon, S. (1979): Side effects associated with lithium therapy. Arch. Gen. Psychiat. 36, 879–887.

    Article  PubMed  CAS  Google Scholar 

  159. Reiser, G., Duhm, J. (1982): Pathways for transport of lithium ions in neuroblastoma x glioma hybrid cells. In: Basic mechanisms in the action of lithium (Emrich, H. M., et al., Hrsg.), S. 36–49. Amsterdam: Excerpta Medica.

    Google Scholar 

  160. Rosenblatt, J. E., Pert, C. B., Tallman, J. F., Pert, A., Bunney, W. E. jr. (1979): The effect of imipramine and lithium on a-and 13-receptor binding in rat brain. Brain Res. 160, 186–191.

    Article  PubMed  CAS  Google Scholar 

  161. Rosser, R. (1976): Thyrotoxicosis and lithium. Br. J. Psychiat. 128, 61–66.

    Article  CAS  Google Scholar 

  162. Rossof, A. H., Robinson, W. A. (Hrsg.) (1980): Lithium effects on granulopoieses and immune function (Adv. Exp. Med. Biol., Vol. 127 ). New York - London: Plenum Press.

    Google Scholar 

  163. Rothstein, G., Clarkson, D., Larsen, W., Grosser, B. I., Athens, J. W. (1978): Effect of lithium on neutrophil mass and production. N. Engl. J. Med. 298, 178–180.

    Article  PubMed  CAS  Google Scholar 

  164. Sachar, E. J., Baron, M. (1979): The Biology of Affective Disorders. Ann. Rev. Neurosci. 2, 505–518.

    Article  PubMed  CAS  Google Scholar 

  165. Saran, B. M. (1980): Electrolyte and water balance. Side-effects of lithium. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 338–346. Lancaster: MTP Press.

    Google Scholar 

  166. Schertel, M.: Dissertation in Vorbereitung.

    Google Scholar 

  167. Schou, M. Juel-Nielsen, N., Strömgren, E., Voldby, H. (1954): The treatment of manic psychoses by administration of lithium salts. J. Neurol. Neurosurg. Psychiat. 17, 250–260.

    Article  PubMed  CAS  Google Scholar 

  168. Schou, M. (1974): Heutiger Stand der Lithiumrezidivprophylaxe bei endogenen affektiven Erkrankungen. Nervenarzt 45, 397–418.

    PubMed  CAS  Google Scholar 

  169. Schou, M. (1978): Lithium for affective disorders. Cost and benefit. In: Mood disorders: The world’s major public health problem ( Ayd, F. J. jr., Taylor, I. J., Hrsg.), S. 117–137. Baltimore: Ayd Medical Communications.

    Google Scholar 

  170. Schou, M. (1979): Lithium as a prophylactic agent in unipolar affective illness. Comparison with cyclic antidepressants. Arch. Gen. Psychiat. 36, 849–851.

    Article  PubMed  CAS  Google Scholar 

  171. Scxou, M. (1979): Artistic productivity and lithium prophylaxis in manic-depressive illness. Br. J. Psychiat. 135, 97–103.

    Article  Google Scholar 

  172. Schou, M. (1979): Lithium in the treatment of other psychiatric and nonpsychiatric disorders. Arch. Gen. Psychiat. 36, 856–859.

    Article  PubMed  CAS  Google Scholar 

  173. Schou, M. (1980): Pharmacology and toxicology of lithium. In: Psychotropic agents, part I: Antipsychotics and antidepressants ( Hoffmeister, F., Stille, G., Hrsg.), S. 583–590. Berlin–Heidelberg–New-York: Springer.

    Google Scholar 

  174. Schou, M. (1980): Lithium-Behandlung der manisch-depressiven Krankheit - Information für Arzt und Patienten. Stuttgart - New York: G. Thieme.

    Google Scholar 

  175. Schou, M. (1980): Lithium treatment of manic-depressive illness. A practical guide. Basel: Karger.

    Google Scholar 

  176. Schou, M. (1980): The recognition and management of lithium intoxication. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 394–413. Lancaster: MTP Press.

    Google Scholar 

  177. Schou, M. (1981): Bibliography on the biology and pharmacology of lithium, 8(review). Neuropsychobiol. 7, 26–55.

    Article  CAS  Google Scholar 

  178. Schou, M., Mellerup, E. T., Rafaelsen, O. J. (1981): Mode of action of lithium. In: Handbook of biological psychiatry, part IV ( Van Praag, H., Hrsg.), S. 805–824. New York–Basel: Marcel Dekker.

    Google Scholar 

  179. Schou, M. (1982): Zum heutigen Stand der Phasenprophylaxe beim manisch-depressiven Krankheitsgeschehen (MDK). Neuropsychiat. Clin. 1, 43–52.

    Google Scholar 

  180. Shaw, D. M. (1975): Lithium and amine metabolism. In: Lithium research and therapy ( Johnson, F. N., Hrsg.), S. 411–423. London: Academic Press.

    Google Scholar 

  181. Sheard, M. H., Marini, J. L., Bridges, C. I., Wagner, E. (1976): The effect of lithium on impulse aggressive behavior in man. Am. J. Psychiat. 133, 1409–1413.

    PubMed  CAS  Google Scholar 

  182. Shepherd, M., Crow, T., Lader, M. H., Johnson, A. L. (1981): Continuation therapy with lithium and amitryptilin in unipolar depressive illness: a controlled trial. Psychol. Med. 11, 409–416.

    Article  Google Scholar 

  183. Siever, J. L., Risch, S. C., Murphy, D. L. (1981): Central cholinergic-adrenergic imbalance in the regulation of affective state. Psychiat. Res. 5, 108–109.

    Article  CAS  Google Scholar 

  184. Siggins, G. R., Schulz, J. E. (1979): Chronic treatment with lithium or desipramine alters discharge frequency and norepinephrine responsiveness of cerebellar Purkinje cells. Proc. Natl. Acad. Sci. (U.S.A.) 76, 5987–5991.

    Article  CAS  Google Scholar 

  185. Sims, A. C. P., White, A. C., Garrey, K. (1978): Problems associated with the analysis and interpretation of saliva lithium. Br. J. Psychiat. 132, 152–154.

    Article  CAS  Google Scholar 

  186. Skoven, I., Thormann, J. (1979): Lithium compound treatment and psoriasis. Arch. Dermatol. 115, 1185–1187.

    Article  PubMed  CAS  Google Scholar 

  187. Small, J. G., Kellams, J. J., Milstein, V., Small, I. F. (1980): Complications with electroconvulsive treatment combined with lithium. Biol. Psychiat. 15, 103–112.

    PubMed  CAS  Google Scholar 

  188. Smith, D. F. (1977b): Behavior of rats given lithium salts. A review. Pharmacopsychiat. 10, 79–88.

    Article  CAS  Google Scholar 

  189. Smulevitch, A. B., Zavidovskaya, G. I., Igonin, A. L., Mikhailova, N. M. (1974): The effectiveness of lithium in affective and schizoaffective psychoses. Br. J. Psychiat. 125, 65–72.

    Article  CAS  Google Scholar 

  190. Spatz, R., Kugler, J., Greil, W., Lorenzi, E. (1978): Das Elektroenzephalogramm bei der Lithium-Intoxikation. Nervenarzt 49, 539–542.

    PubMed  CAS  Google Scholar 

  191. Spring, G., Frankel, M. (1981): New data on lithium and haloperidol incompatibility. Am. J. Psychiat. 138, 818–821.

    PubMed  CAS  Google Scholar 

  192. Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., Bloom, F. E. (1982): Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity. Brain Res. 232, 391–400.

    Article  PubMed  CAS  Google Scholar 

  193. Stein, R. S., Beaman, C., Ali, M. Y., Hansen, R., Jenkins, D. D., Jume’an, H. G. (1977): Lithium carbonate attenuation of chemotherapy-induced neutropenia. N. Engl. J. Med. 297, 430–431.

    Article  PubMed  CAS  Google Scholar 

  194. Szentistvanyi, I., Janka, Z., Joô, F., Rimanoczy, A., Juhasz, A., Latzkovits, L. (1979): Na-dependent Li-transport in primary nerve cell cultures. Neurosci. Lett. 13, 157–161.

    Article  PubMed  CAS  Google Scholar 

  195. Thiels, C. (1980): Psychopharmaka und Schwangerschaft. Eine Übersicht. Pharmacopsychiat. 13, 301–317.

    Article  CAS  Google Scholar 

  196. Thomsen, K. (1978): Renal handling of lithium at nontoxic and toxic serum lithium levels. Danish Med. Bull. 25, 106–115.

    CAS  Google Scholar 

  197. Thomsen, K., Schou, M. (1968): Renal lithium excretion in man. Am. J. Physiol. 215, 823–827.

    PubMed  CAS  Google Scholar 

  198. Tilkian, A., Schroeder, J., KAO, J. J., Hultgren, H. N. (1976): The cardiovascular effects of lithium in man–review of literature. Am. J. Med. 61, 665–670.

    Article  PubMed  CAS  Google Scholar 

  199. Treiser, S. L., Cascio, C. S., O’donohue, T. L., Thoa, N. B., Jacobowitz, D. M., Kellar, K. J. (1981): Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213, 1529–1531.

    Article  PubMed  CAS  Google Scholar 

  200. Tress, W., Haag, H. (1979): Vergleichende Erfahrungen mit der rezidivprophylaktischen Lithium-Langzeitmedikation bei schizoaffektiven Psychosen. Nervenarzt 50, 524–526.

    PubMed  CAS  Google Scholar 

  201. Turner, J. G., Brownlie, B. E. W., Sadler, W. A., Jensen, C. H (1976): An evaluation of lithium as an adjunct to carbimazole treatment in acute thyrotoxicosis. Acta Endocrin. 83, 86–92.

    CAS  Google Scholar 

  202. Tyrer, S., Shdpsin, B. (1980): Neural and neuromuscular side effects of lithium. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 289–309. Lancaster: MTP Press.

    Google Scholar 

  203. Van Calker, D., Hamprecht, B. (1980): Effects of neurohormones on glial cells. In: Advances in cellular neurobiology (Fedoroff, S., Hertz, L., Hrsg.), Vol. 1, S. 217. 32–67. New York: Academic Press.

    Google Scholar 

  204. Vendsborg, P. B., Bech, P., Rafaelsen, O. J. (1976): Lithium treatment and weight gain. Acta Psychiat. Scand. 53, 139–147.

    CAS  Google Scholar 

  205. Vendsborg, P. B. (1979): Lithium treatment and glucose tolerance in manic-melancholic patients. Acta Psychiat. Scand. 59, 306–316.

    CAS  Google Scholar 

  206. Vestergaard, P. (1980): Renal side-effects 219. of lithium. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 345–357. Lancaster: MTP Press.

    Google Scholar 

  207. Vestergaard, P., Schou, M., Thomsen, K. (1982): Monitoring of patients in prophylactic lithium treatment. An assessment based on recent kidney studies. Br. J. Psychiat. 140, 185–187.

    Article  CAS  Google Scholar 

  208. Visca, U., Mensi, F., Spina, M. P., Bomba-Ra, R., Giraldi, B., Massari, A., Rossi, F., Santi, G. (1979): Prevention of antiblastic neutropenia with lithium carbonate. Lancet 1, 779.

    Article  PubMed  CAS  Google Scholar 

  209. Vizi, E. S. (1975): Lithium and acetylcholine metabolism. In: Lithium research and therapy ( Johnson, F. N., Hrsg.), S. 391–409. London: Academic Press.

    Google Scholar 

  210. Wahlin, A., Bucht, G., Von Knorring, L., Smigan, L. (1980): Kidney function in patients with affective disorders with and without lithium therapy. Int. Pharmacopsychiat. 15, 253–259.

    CAS  Google Scholar 

  211. Wasilewski, B., Steinbock, H., Kohl, R., Greil, W., Bottermann, P. (1978): Schilddrüsenfunktion bei der Lithiumprophylaxe. Arzneim.-Forsch./Drug Res. 28, 1297–1298.

    CAS  Google Scholar 

  212. Wehr, T., Goodwin, F. K. (1980): Desynchronization of circadian rhythms as a possible source of manic-depressive cycles. Psychopharmacol. Bull. 16, 19–20.

    Google Scholar 

  213. Wehr, T. A., Goodwin, F. K. (1981): Biological rhythms and psychiatry. In: American handbook of psychiatry, Vol. 7: Advances and new directions ( Arrieti, S., Hrsg.), S. 46–74. New York: Basic Books.

    Google Scholar 

  214. Weinstein, M. R., Goldfield, M. D. (1975): Cardiovascular malformations with lithium use during pregnancy. Am. J. Psychiat. 142, 529–531.

    Google Scholar 

  215. Weinstein, M. R. (1980): Lithium treatment of women during pregnancy and in post-delivery period. In: Handbook of lithium therapy ( Johnson, F. N., Hrsg.), S. 421–429. Lancaster: MTP Press.

    Google Scholar 

  216. Wirz-Justice, A. (1982): The effect of lithium on the circadian system. In: Basic mechanisms in the action of lithium ( Emrich, H. M., et al., Hrsg.), S. 249–258. Amsterdam: Excerpta Medica.

    Google Scholar 

  217. Wolff, J. (1979): Lithium interactions with the thyroid gland. In: Lithium: Controversies and unresolved issues ( Cooper, T. B., et al., Hrsg.), S. 552–564. Amsterdam: Excerpta Medica.

    Google Scholar 

  218. Wraae, O. (1978): The pharmacokinetics of lithium in the brain and cerebrospinal fluid and serum of rat. Br. J. Pharmacol. 64, 273–279.

    PubMed  CAS  Google Scholar 

  219. Zatz, M. (1979): Low concentrations of lithium inhibit the synthesis of cyclic AMP and cyclic GMP in the rat pineal gland. J. Neurochem. 32, 1315–1321.

    Article  PubMed  CAS  Google Scholar 

  220. Michell, B. (1982): A link between lithium Münchner medizinische Wochenschrift and receptors. TIBS, 387–388.

    Google Scholar 

  221. Pfaffenrath, V., Prosiegl, M., Neu, I. (1982): Therapie des Clusterkopfschmerz. 124, 293–296.

    CAS  Google Scholar 

Download references

Authors
  1. W. Greil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Van Calker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Universitätsklinik Wien, Lazarettgasse 14, A-1097, Wien, Österreich

    Gerhard Langer (Oberarzt) (Oberarzt)

  2. Osianderstraße 22, D-4700, Tübingen 1, Bundesrepublik Deutschland

    Hans Heimann (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen) (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag/Wien

About this chapter

Cite this chapter

Greil, W., Van Calker, D. (1983). Lithium: Grundlagen und Therapie. In: Langer, G., Heimann, H. (eds) Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7645-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7645-0_5

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7646-7

  • Online ISBN: 978-3-7091-7645-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation